It is curious that today we are entrapped into a system that provides for essentially ineffective anti-inflammatory agents. Thus it was many years ago that it was noted that the willow tree flourished under damp conditions; the very conditions which were believed to provoke arthritic episodes. From these two beliefs it seemed inevitable to take an extract of the bark of the willow tree and treat arthritics. The era of the 'aspirin-like' drugs had arrived. This opening paragraph has been unashamedly stolen from an earlier lecture by Professor E. G. L. Bywaters on the development of the salicylates.
The realization of the effectiveness of the salicylates unfortunately led to a disservice to those actively engaged in the search for new therapeutic agents. All workers became caught up in a field where every new experimental model of inflammation had to fulfil the criteria of showing salicylate activity. Thus for years groups of workers have assaulted animals with a variety of irritants into various sites. As long as the subsequent reaction could be suppressed by salicylate it was seized upon as a potential new test system. Groups have exercised their ingenuity over the years in an attempt to explain the mode of action of these drugs. Each new step in the analysis of the inflammatory reaction has been used in the search for the mode of action of these 'aspirinlike' drugs. Pharmacologists have endlessly pursued the effect of salicylates upon various mediators of the inflammatory response. More recently attention has focused upon the cellular kinetics of the chronic reaction. The tests used to study the mode of action of steroids have ranged from the effect of these compounds on biochemical parameters such as oxidative phosphorylation (Adams, 1958; Dawkins, Gould, Sturman, and Smith, 1967) , the enzymatic formation of pharmacologically active mediators, the effect on immunological responsiveness. A great deal of interest has lately been provoked by the work of Vane and his colleagues (see Vane, 1972) who showed clearly an inhibition of the prostaglandin-forming system by aspirin-like drugs. It remains to be seen which of these many hypotheses will stand the test of time. Certainly the realization that the ubiquitous family of prostaglandins may modulate the inflammatory response by the process ofmutual antagonism is significant (Velo, Dunn, Giroud, Timsit, and Willoughby, 1973) . In addition Prostaglandin E (PGE) may provoke a rise in intracellular cyclic AMP (Weissmann, Dukor, and Zurier, 1971) , which is essentially an anti-inflammatory process; this seems difficult to reconcile with the role of these fatty acids as possible mediators. Despite all these efforts it is not possible to state clearly today the mode of action of these compounds.
A further mistaken concept has opened another new pathway of anti-inflammatory therapy, namely the mode of action of penicillamine. This interesting, albeit toxic, drug appears clinically to have a specific activity directed towards rheumatoid arthritis (RA). Yet the basic rationale that it should act by lowering the titre ofrheumatoid factor has not been established. A major problem with penicillamine and similar compounds is that of detecting activity in the animal model. E. C. Huskisson and others (unpublished, 1975) have recently shown the lack of correlation between the clinical effectiveness of penicillamine in RA and its ability to modify levels of rheumatoid factor (Fig. 1) .
It appears that a major hold-up is occurring in the development of new anti-inflammatory therapy which is partially due to failure of communication between clinical rheumatologists and the basic scientists. A few years ago at St. Bartholomew's Hospital we developed the concept of scientists attending ward rounds and clinicians working at the bench. This integration was not easy. In the first instance two different languages were being spoken with attendant jargon. Each 'expert' was afraid to display his ignorance in the other 'expert's' field. Fortunately, with tact and patience this has been overcome; now the situation of free exchange exists. Giroud, 1975) . The reason for selecting the pleural cavity as a site of injection was the ease with which crystals and volume of exudate could be quantitatively measured. Fig. 4 shows the basic reaction to the intrapleural injection of calcium pyrophosphate. It Mono.--.
-

30-
we had found that intrapleural injection of this irritant permitted a more precise quantitation of the inflammatory response than the conventional subcutaneous injection into the hind paw (Di Rosa, Giroud, and Willoughby, 1971 ; Velo and others, 1973) .
Once again the reaction was maximal by 6 hours and then subsided (Fig. 5 ). Certain differences were apparent in the cellular sequence of events, e.g. the ultimate dominance of the mononuclear cells which contrasted with the crystal model described above. Carrageenan produces a complex inflammatory response, e.g. it causes activation of the alternate pathway of the complement system. Its long lasting effects are to produce a granuloma composed of long-lived mononuclear cells (Ryan and Spector, 1970 ) with a low turnover rate. For this reason Allison and Davies (1974) (Capasso, Dunn, Yamamoto, and Willoughby, 1975) .
The next model, developed in our laboratory largely by the efforts of Dr. S. Yamamoto and his colleagues (Yamamoto, Dunn, Capasso, Deporter, and Willoughby, 1975a) , was cell-mediated immunity in the guinea pig. Normally this is produced as a cutaneous lesion which depends upon subjective assessment of erythema, induration, and at best an approximation of the number of cells from a histological section. There have been a few exceptions to this method of inducing delayed hypersensitivity (Apicella and Allen, 1969; Leibowitz, Kennedy, and Lessof, 1973) . We decided to use the pleural cavity of the guinea pig and thus could reasonably standardize our different models. The method was to sensitize the guinea pigs with complete Freund's adjuvant and then challenge with PPD intrapleurally. In marked contrast to the other models this reaction was delayed in onset, reaching a maximum at 18-24 hours (Fig.  6 ). The dominant cell type was the mononuclear cell. Reduction of complement failed to effect the reaction in those guinea pigs treated with cobra venom factor. Macrophage inhibition factor was detectable in the exudates (a study shortly to be published by Yamamoto, Dunn, and Willoughby, 1976) .
To study immediate hypersensitivity the reverse passive Arthus reaction was performed in the pleural cavity of rats. Once again this permitted the precise quantitation of cells and exudate. Highly purified rabbit anti-bovine serum albumin (BSA) was injected intrapleurally into rats 20 minutes after intravenous injection of BSA (Yamamoto, Dunn, Capasso, Deporter, Giroud, and Willoughby, 1975b ).
This reaction was again rapid in onset, becoming maximal at 6 hours, dominated by polymorphonuclear leucocytes. Depletion of complement titres reduced the inflammatory response when adjudged by volume of exudate and numbers of cells (Fig.  7) .
We were thus armed with a battery of tests which had all the appropriate characteristics expected of each model. From clinical experience the crystal arthropathy was predictably very acute. The cellmediated immunity was dominated by mononuclear cells delayed in onset, and associated with macrophage inhibition factor activity. The Arthus reaction showed immediate hypersensitivity, was fast in onset, and at its peak was dominated by polymorphonuclear cells. The models were appropriately depen- group.bmj.com on June 15, 2017 -Published by http://ard.bmj.com/ Downloaded from dent or independent of complement as predicted. The main advantage of these tests was the site of inflammation, which permitted easy and accurate harvesting of the exudate and cells counted and differentiated with precision. The exudates so collected were analysed for various parameters, which are reported elsewhere (Willoughby and others, 1975; Capasso and others, 1975; Yamamoto and others, 1975a, b) .
The reactions had common features in the release of the mediators (Capasso and others, 1975 Thus each of the models examined had different characteristics, and even the development of cyclic AMP within cells was unique unto each particular model.
The development of these different models as tests for the assay of anti-inflammatory drugs seems to be logical. The ultimate development of the crystalinduced pleurisy will be dependent upon the identification of the different crystals isolated from human synovial fluid. After their identification by the methods described above, diffraction patterns, probe analysis, etc., these crystals will then be injected into the pleural cavity of rats. It is hoped this will lead to better methods of treatment of those conditions in which crystals are observed, and is currently being pursued by P. Dieppe and his colleagues at St. Bartholomews.
Why the emphasis on the immunological models and what is their relevance in the search for new therapy? We agree completely with the hypothesis of a previous Heberden Oration by Glynn (1968) , in which he proposed that inflammation could produce modified tissue proteins. These subsequently will not be recognized as 'self' and act as antigens with the perpetuation of an inflammatory response. Dumonde and Glynn's (1962) original experiments showed that an inflammatory response could be enhanced by prior sensitization with the products of an inflammatory reaction. We have extended these observations and shown that by injecting the products of an inflammatory granuloma into neonatal rats they become unresponsive to subsequent inflammatory stimuli (Giroud, Timsit, Spector and Willoughby, 1972) .
The final important feature ofchronic inflammation is a close study of the kinetics of the macrophage. Recently Allison and Davies (1974) proposed a scheme whereby the macrophage was envisaged as the central important cell in chronic inflammation. To include this important aspect of the inflammatory response we used a simple model of implanting glass cover slips subcutaneously into mice, described originally by Ryan and Spector (1970) . The cover slips may be removed at various times after implantation and rapidly screened for the area covered by cells. In addition, closer examination using thymidine gives an indication of the rate of turnover of these cells. Normally one can count the total numbers of binucleated and giant cells. The application of this test to the assessment of anti-inflammatory drugs has recently been described in detail by Giroud and others (1973) .
It is of interest that nonsteroidal anti-inflammatory drugs affect the earliest phase of the response, i.e. 2 days, but have little or no effect at 7 days. In contrast, the steroidal drugs have a more profound effect at 7 days. A novel type of anti-inflammatory agent has been shown to have activity, namely a slow- Table shows such a mixture of results that could conceivably be presented after a typical laboratory screen. It can be seen that using the test carrageenan paw oedema the product 'X' was negative, i.e. no anti-inflammatory activity. Similarly the compound 'X' had no effect on the primary lesion of adjuvant arthritis-once again not anti-inflammatory. In contrast there was marked suppression of the secondary lesions of adjuvant-induced polyarthritis. This suggests an immunosuppressant effect on cellmediated immunity.
The investigators would then have turned to the model of Glynn arthritis and found that with constant dosing up to day 25 there was a suppression as measured by histology or thermography. If the arthritis was allowed to become established and treatment started on day 22, once again the compound would appear to be ineffective-not anti-inflammatory. The results using the implanted glass cover slip would be negative initially, but if a 5-day pretreatment regimen was used, suppression would be observed. This mixture of activity which indeed we have seen recently should suggest a slow acting drug.
Thus the clinician should not expect to see antiinflammatory activity in too short a clinical trial.
If the drug displayed activity on, say, the delayed hypersensitivity reaction described above or in an immediate hypersensitivity reaction, the clinician should be prepared to monitor his patients for changes in responsiveness to cell-mediated immunity or to immunoglobulin levels.
There are a host of parameters easily measured in animals which if positive should be measured in man. Certainly in view of the variations existing among the Much of the foregoing may seem obvious but it is nevertheless amazing how neglected are some of these aspects. Certainly it is vital that scientists and clinicians work in each other's environment. Indeed international collaboration in this type of study has proved exciting and intellectually stimulating.
In conclusion it is hoped that by extracting more information from the arthropathies in man and using this information to establish new test systems we will arrive at new therapy. This is in contrast to creating animal models which respond to the present classical nonsteroidal anti-inflammatory drugs, since these models can only lead to the development of further old-fashioned therapy.
